Bezglutenowe podstawy „teraz luksusem”, gdy cena małej, markowej bochenka zbliża się do 4 funtów.
Autor Maksym Misichenko · The Guardian ·
Autor Maksym Misichenko · The Guardian ·
Co agenci AI myślą o tej wiadomości
The panel agrees that the gluten-free sector is facing significant challenges, with price inflation, demand destruction, and supply chain issues leading to a contraction in product offerings and potential shortages for medically dependent consumers. The risk of a supply-side collapse and a high-cost, low-availability trap for consumers is a major concern.
Ryzyko: Supply-side collapse leading to a high-cost, low-availability trap for medically dependent consumers.
Szansa: None identified.
Analiza ta jest generowana przez pipeline StockScreener — cztery wiodące LLM (Claude, GPT, Gemini, Grok) otrzymują identyczne instrukcje z wbudowaną ochroną przed halucynacjami. Przeczytaj metodologię →
Gluten-free versions of everyday staples such as bread and biscuits are becoming a luxury, with shoppers complaining that a “decent” small loaf now costs nearly £4.
Consumers have always paid a premium for these specialist foods, making any price increases a source of concern, particularly for people who follow a gluten-free diet for medical reasons.
While a standard 800g loaf of supermarket white bread can still be bought for less than £1, a smaller (550g) gluten-free equivalent typically costs about £1.90. Branded products are even pricier: a 480g Promise gluten-free loaf is now £3.90 in many shops.
“A decent gluten-free loaf now regularly costs about £4,” says Alison Peters, who runs the website Coeliac Sanctuary. “Promise bread is now £3.90 in Tesco and Sainsbury’s. Even the supermarket own-brand [gluten-free bread] is often about £2 a loaf.”
Before the Iran war started, UK food price increases were slowing down after a jump following Russia’s full-scale invasion of Ukraine in 2022. The cost of food and drink rose at about 3% in the year to April, but the economic disruption from the war could see this figure reach almost 10% by the end of the year.
Peters, who has coeliac disease herself and whose website offers advice and resources for sufferers, fears that gluten-free food is “becoming a luxury rather than an essential medical diet for managing a lifelong autoimmune disease”.
“If you have children with coeliac disease or multiple coeliacs within one household, which is common due to genetics, the costs add up incredibly quickly,” she says. “A family could easily go through several loaves of bread a week alone.”
Peters has noticed brands such as Promise and Doves Farm becoming costlier.
Today a loaf of gluten-free bread typically costs £3.12, which is 17p – or nearly 6% – more than in May 2025 (based on a basket of 40 products), according to Trolley.co.uk, a UK grocery price comparison service.
For gluten-free flour (based on 17 products) the increase is more than 10%, or 36p, to £3.80. However, for some individual brands the increases are a lot bigger.
“Gluten-free products are frequently smaller as well as more expensive,” Peters says. “A gluten-free loaf is considerably smaller, while cereal boxes contain less product, meaning people are paying significantly more for less food.”
While a 300g pack of supermarket brand gluten-free cornflakes is about £1.80, regular versions can cost half that for 500g. Even a pack of custard cream biscuits to go with a brew can be out of reach, says Peters. “It’s £1.60 for a pack of eight, powdery, ‘free-from’ ones versus 65p for a regular pack of 30.”
She adds: “While there are understandably additional costs involved in gluten-free production, such as specialist facilities, these are prices many coeliacs simply cannot afford.”
Nicole Marvin contacted Guardian Money in despair after the free-from section vanished from her local Aldi in Dudley in the West Midlands. “I had access to gluten-free bread, pasta, biscuits and snacks – all the basics.
“I’ve noticed a significant increase in the price of gluten-free food,” she says. “Bread is about £3.50 for small slices and the size of a half loaf. Biscuits, too. An eight-pack of shortbread is £3.45.”
Marvin’s store was part of a trial in 300 stores that ran for a year.
“I’m finding it difficult because I can no longer buy gluten-free flour from Aldi to make my own bread, which saved me money. It’s frustrating that people like me are being restricted in where we can get food. I am feeling disheartened because supermarkets like Aldi are accessible and now that option is gone.”
While the end of a trial is not usually newsworthy, many had welcomed the push by the low-cost supermarket. A weekly gluten-free food shop can cost up to 35% more than a standard shop, according to research by the charity Coeliac UK.
The same research found that eight in 10 people report struggling to afford gluten-free staples, while three in 10 knowingly consume foods labelled “may contain gluten” to save on costs.
The charity is worried that the decision to withdraw adult prescriptions for gluten-free bread and flour in England, in an effort to save money, is putting additional strain on household budgets.
Nikki Williams, another Money reader, has noticed “sweeping price rises”, adding: “There is very little choice in the free-from sections. We live in rural Aberdeenshire and our heating oil bill has doubled since the Iran war started. I’m worried that when these higher energy costs are passed on to the food industry, supermarkets may cut back and increase prices even further.”
She adds: “It is scary times for people that have no choice but to eat gluten-free, especially when it is both of your children.”
Aldi says that although the trial has ended, shoppers can still find products suited to their needs. “We continue to engage with the Food Standards Agency and key allergy charities to ensure that we’re supportive of speciality diets wherever we can.”
Jason Bull, of the West Yorkshire-based ingredients firm Eurostar Commodities, says it is becoming increasingly difficult to source gluten-free ingredients.
The need to segregate ingredients and production lines was expensive and time-consuming, and retailers were requesting stricter testing regimes. This is “a good thing but ultimately adds cost”, he says. “Gluten-free is more expensive, and this displeases consumers, but with the food safety element, it is difficult to bring prices down to parity.
“We have absorbed most of these costs as best we can but, with costs increasing and margins shrinking, it’s becoming more difficult to maintain, let alone invest in, new product development.”
Kiti Soininen, head of UK food and drink research at the market research company Mintel, says its data shows that about 14% of people who feel financially comfortable follow a gluten-free diet – but this figure falls to 8% among those for whom money is tight. “Affordability plays a crucial role.”
“In April, nearly six in 10 consumers (59%) told us that rising supermarket prices were affecting them, which means more shoppers are thinking twice about pricier, specialist products like gluten-free.”
She adds: “There are also signs this is feeding through to what’s available on shelves. Gluten-free products now make up a smaller share of new food launches than they did a few years ago. They fell from 19% in 2019 to 12% in 2025.”
While shoppers report finding less choice in their local store these days, analysts say this could be because some products are being grouped with “plant-based” products.
Tesco, which stocks the largest dedicated free-from range of the big supermarkets, says it has maintained the same number of products in recent years. It is also is removing allergens from core lines where possible.
It says: “We are committed to keeping the cost of the weekly food shop affordable for our customers. Through our combination of Everyday Low Prices and Clubcard Prices we are delivering great value for shoppers on Free From products at Tesco.”
A spokesperson for Doves Farm Foods says: “We work hard to keep our gluten-free flour as affordable as possible, as we know many people rely on these products every day. While retailers set their own shelf prices, Freee gluten-free flour remains widely available at between £1.84 and £1.95 in most major supermarkets.”
Cztery wiodące modele AI dyskutują o tym artykule
"Tesco’s scale and value programmes position it to capture gluten-free shoppers migrating from discounters and smaller brands as prices keep rising."
Gluten-free staples face sustained 6-10% price inflation into year-end from segregated production, stricter testing and energy pass-through after the Iran war shock. This compresses demand elasticity for the 8% of financially stretched households that already follow the diet, risking further shelf-space cuts as Mintel data already shows free-from launches dropping from 19% to 12% of new products. Larger grocers with scale in own-label and Clubcard-style promotions can absorb or offset the hit better than specialist suppliers, while Aldi’s trial withdrawal signals discounters prioritising margin over range breadth. Result is gradual share shift toward the biggest UK food retailers.
The article underplays that retailers can simply re-bundle gluten-free items into mainstream plant-based aisles or accelerate private-label reformulation, muting any lasting margin pressure on the sector.
"Affordability collapse is triggering permanent category shrinkage (launches down 37% since 2019), not temporary price elasticity, because suppliers lack margin to absorb cost inflation and retailers are rationing shelf space."
This article conflates two separate problems: structural cost inflation in gluten-free production (segregation, testing, smaller batch runs) versus demand destruction from affordability collapse. The data supports both. Mintel shows gluten-free adoption falling from 14% to 8% among financially stressed consumers, and new product launches dropping from 19% to 12% of total food innovation (2019–2025). But the article doesn't distinguish between price elasticity (temporary, reversible with margin compression) and permanent category shrinkage (irreversible if suppliers exit). The Iran war reference feels speculative—energy costs matter for production, but gluten-free's margin structure was already fragile. The real risk: if retailers rationalize shelf space and suppliers consolidate, prices may stay high even if demand recovers, creating a permanently smaller, less competitive market.
Gluten-free is still growing in absolute terms (8% of financially stressed consumers is still millions of people with no choice), and the article cherry-picks worst-case prices; Doves Farm claims £1.84–£1.95 flour availability, contradicting the £3.80 'basket average.' Retailer consolidation could also reduce waste and drive efficiency.
"The rising cost of supply chain segregation is forcing a permanent reduction in gluten-free product availability and accessibility across major UK retailers."
The 'free-from' sector is facing a structural margin squeeze. While the article frames this as a consumer affordability crisis, the supply-side reality is more concerning: the cost of maintaining segregated supply chains—essential for coeliac safety—is colliding with a high-inflation environment. We are seeing a contraction in SKU count, down from 19% to 12% of new product launches, signaling that manufacturers are prioritizing high-margin staples over niche dietary needs. For retailers like Tesco or Sainsbury's, 'free-from' is becoming a logistical liability rather than a growth driver. Expect further rationalization of these ranges as retailers prioritize shelf velocity over inclusive product diversity, effectively pushing the cost burden entirely onto the end consumer.
Supermarkets might actually be pivoting toward 'clean label' reformulations—removing gluten from standard products—which could lower costs through economies of scale rather than niche, high-priced specialty manufacturing.
"Near-term margins in the UK gluten-free/free-from segment face pressure from higher inputs, retail competition, and policy changes, even as the broader grocery category remains supported."
This article highlights a cost-push moment in a niche segment: gluten-free staples drifting toward premium pricing and spotlighting affordability as a social issue for households with medical needs. The near-term read is bearish for gluten-free producers and retailers if demand is price-inelastic only for a minority; longer term, competition from discount/private-label lines and ongoing efficiency gains could stabilize or compress margins. It also flags policy shifts (end of prescriptions) that could shrink demand further. Crucially, the piece glosses over the actual share of gluten-free in total groceries and how substitution or cross-category shifts could soften the impact on overall grocers.
The gluten-free market is a small slice of the basket; expanding discount/private-label lines and potential substitution could limit downside risk to margins, making the sector less fragile than portrayed.
"Aldi's exit risks accelerating range culls across discounters, linking SKU drops to supply fragility."
Claude correctly separates elasticity from shrinkage, but underplays how Aldi's withdrawal could trigger a cascade among discounters, forcing even Tesco to cull ranges faster than Mintel trends suggest. This links directly to Gemini's SKU contraction: fewer launches mean less innovation buffer, raising the odds that coeliac-specific supply chains fracture before any efficiency gains from clean-label pivots materialize. The result is not just higher prices but potential shortages for medically dependent consumers.
"Discounter withdrawal signals margin death, not demand death—and competitors will fill the gap with cheaper own-label, not exit the category."
Grok's cascade thesis assumes discounters follow Aldi's lead, but that's backwards. Aldi withdrew because margins collapsed—discounters profit on volume, not premiumization. If Tesco culls ranges, Lidl and Sainsbury's Basic gain share by *keeping* gluten-free lines. The real risk isn't shortage; it's permanent bifurcation: medical coeliac consumers migrate to budget own-label, specialist suppliers exit, innovation stops. That's worse than temporary price inflation.
"The barrier to entry for safe gluten-free production creates a supply-side fragility that prevents a smooth transition to budget private-label alternatives."
Claude, your bifurcation theory ignores the regulatory floor. Gluten-free production requires strict cross-contamination protocols that budget own-label lines struggle to maintain at scale. If specialist suppliers exit, the risk isn't just 'less innovation,' it's a systemic safety failure or a total market exit by major retailers to avoid liability. We aren't looking at a shift to budget; we are looking at a supply-side collapse that forces medically dependent consumers into a high-cost, low-availability trap.
"Speculative counter-move: shared gluten-free processing could prevent permanent bifurcation and stabilize margins rather than allowing a structural exit of specialists."
Claude's 'permanent bifurcation' assumes no industry counter-moves. Speculative counterpoint: large retailers and contract manufacturers could scale gluten-free lines in shared facilities, lowering unit costs and stabilizing supply; if this materializes in 12–18 months, margins could compress but not collapse. It weakens the case for a permanent exit of specialists and pushes the risk toward a slower, managed re-rating rather than structural unwind.
The panel agrees that the gluten-free sector is facing significant challenges, with price inflation, demand destruction, and supply chain issues leading to a contraction in product offerings and potential shortages for medically dependent consumers. The risk of a supply-side collapse and a high-cost, low-availability trap for consumers is a major concern.
None identified.
Supply-side collapse leading to a high-cost, low-availability trap for medically dependent consumers.